Table 3.

Adjusted effect sizes (OR) with 95% CIs of risk factors for COVID-19 hospitalization

Diagnosis (Group)	Adjusted OR (95% CI) (all)	Adjusted OR (95% CI) (male)	Adjusted OR (95% CI) (female)
Hemiplegia or paraplegia	1.61 (1.44–1.79)***	1.73 (1.50–1.99)***	1.44 (1.21–1.71)***
Chronic obstructive pulmonary disease	1.48 (1.43–1.53)***	1.46 (1.40–1.53)***	1.51 (1.43–1.59)***
Diabetes without complications	1.41 (1.37–1.46)***	1.33 (1.28–1.39)***	1.52 (1.45–1.60)***
Renal disease	1.39 (1.34–1.44)***	1.36 (1.29–1.43)***	1.42 (1.35–1.49)***
Diabetes with complications	1.35 (1.29–1.42)***	1.39 (1.30–1.48)***	1.32 (1.22–1.42)***
Rheumatoid disease	1.32 (1.23–1.43)***	1.19 (1.04–1.36)**	1.39 (1.26–1.52)***
Mild liver disease	1.26 (1.21–1.32)***	1.22 (1.15–1.29)***	1.33 (1.24–1.42)***
Dementia	1.25 (1.20–1.31)***	1.30 (1.21–1.39)***	1.22 (1.15–1.29)***
AIDS/HIV	1.18 (0.79–1.78)	0.98 (0.58–1.67)	1.62 (0.85–3.11)
Congestive heart failure	1.16 (1.12–1.20)***	1.18 (1.12–1.24)***	1.14 (1.08–1.21)***
Moderate or severe liver disease	1.12 (0.98–1.28)	1.11 (0.94–1.31)	1.18 (0.93–1.49)
Cerebrovascular disease	1.12 (1.08–1.15)***	1.10 (1.06–1.15)***	1.13 (1.08–1.19)***
Peptic ulcer disease	1.10 (1.02–1.20)**	1.08 (0.96–1.21)	1.14 (1.00–1.29)**
Peripheral vascular disease	1.09 (1.05–1.14)***	1.12 (1.07–1.18)***	1.06 (1.00–1.12)*
Cancer (any malignancy)	1.03 (0.99–1.07)	1.01 (0.96–1.06)	1.06 (1.00–1.12)**
Acute myocardial infarction	0.97 (0.92–1.03)	0.95 (0.88–1.01)	1.03 (0.94–1.13)
Metastatic solid tumour	0.84 (0.77–0.91)***	0.78 (0.69–0.87)***	0.93 (0.82–1.06)
Total number of observations	280,440	144,366	136,074

Authors’ calculation based on [16, 17]

*, **, *** refer to significance at the p < 0.10, p < 0.05, and p < 0.01 level, respectively. Results refer to odds ratios (OR) and 95% confidence intervals (95% CI) obtained from logistic regression; analyses were adjusted for age group, sex and health care region